Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S J Fleming

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Journal of Clinical Apheresis|January 1, 1991
Hemolytic uremic syndrome/thrombotic thrombocytopenic purpura: outcome with plasma exchangeA W Roberts, E A Gillett, S J Fleming
Clinical Nephrology|August 1, 1993
Effect of withdrawal of folic acid supplementation in maintenance hemodialysis patientsJ Westhuyzen, K Matherson, R Tracey, et al.
Postgraduate Medical Journal|April 1, 1987
Familial dysalbuminaemic hyperthyroxinaemiaS J Fleming, G F Applegate, C G Beardwell
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 1, 1994
Tubular nephrotoxicity after cardiac surgery utilising cardiopulmonary bypassJ Westhuyzen, D C McGiffin, J McCarthy, et al.
American Journal of Nephrology|January 1, 1991
Dialyser reprocessing with RenalinS J Fleming, K Foreman, K Shanley, et al.
American Journal of Nephrology|January 1, 1992
Effect of dialyzer reprocessing with Renalin on serum beta-2-microglobulin and complement activation in hemodialysis patientsJ Westhuyzen, K Foreman, D Battistutta, et al.
The British Journal of Surgery|April 1, 1988
Erosion of rectum by Tenckhoff catheterM H Jamison, S J Fleming, P Ackrill, et al.
The Journal of Infection|May 1, 1991
Poor response to a recombinant hepatitis B vaccine in dialysis patientsS J Fleming, D M Moran, W G Cooksley, et al.
Clinical Nephrology|November 1, 1990
Use of aminohydroxypropylidene bisphosphonate (AHPrBP, "APD") for the treatment of hypercalcemia in patients with renal impairmentA S Yap, G I Hockings, S J Fleming, et al.
Clinical Nuclear Medicine|March 1, 1994
Increased skeletal uptake of Tc-99m methylene diphosphonate in milk-alkali syndromeS B Campbell, D J Macfarlane, S J Fleming, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Journal of Clinical Apheresis|January 1, 1991
Hemolytic uremic syndrome/thrombotic thrombocytopenic purpura: outcome with plasma exchangeA W Roberts, E A Gillett, S J Fleming
Clinical Nephrology|August 1, 1993
Effect of withdrawal of folic acid supplementation in maintenance hemodialysis patientsJ Westhuyzen, K Matherson, R Tracey, et al.
Postgraduate Medical Journal|April 1, 1987
Familial dysalbuminaemic hyperthyroxinaemiaS J Fleming, G F Applegate, C G Beardwell
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 1, 1994
Tubular nephrotoxicity after cardiac surgery utilising cardiopulmonary bypassJ Westhuyzen, D C McGiffin, J McCarthy, et al.
American Journal of Nephrology|January 1, 1991
Dialyser reprocessing with RenalinS J Fleming, K Foreman, K Shanley, et al.
American Journal of Nephrology|January 1, 1992
Effect of dialyzer reprocessing with Renalin on serum beta-2-microglobulin and complement activation in hemodialysis patientsJ Westhuyzen, K Foreman, D Battistutta, et al.
The British Journal of Surgery|April 1, 1988
Erosion of rectum by Tenckhoff catheterM H Jamison, S J Fleming, P Ackrill, et al.
The Journal of Infection|May 1, 1991
Poor response to a recombinant hepatitis B vaccine in dialysis patientsS J Fleming, D M Moran, W G Cooksley, et al.
Clinical Nephrology|November 1, 1990
Use of aminohydroxypropylidene bisphosphonate (AHPrBP, "APD") for the treatment of hypercalcemia in patients with renal impairmentA S Yap, G I Hockings, S J Fleming, et al.
Clinical Nuclear Medicine|March 1, 1994
Increased skeletal uptake of Tc-99m methylene diphosphonate in milk-alkali syndromeS B Campbell, D J Macfarlane, S J Fleming, et al.
Pageof 5